Pricing

KNOLL CAPITAL MANAGEMENT, LLC

0 followers ·
MIAMI FL
13F Summary

Subscription Required

Equal-WT
WhaleScore 2.0 ?

85

S&P 500
WhaleScore ?

Subscription Required

Equal-WT
WhaleScore 1.0 ?

Knoll Capital Management is based out of Miami. Their last reported 13F filing for Q4 2023 included $120,759,584 in managed 13F securities and a top 10 holdings concentration of 74.17%. Knoll Capital Management's largest holding is Biohaven Pharmaceutical Holding Co Ltd with shares held of 490,422. Whalewisdom has at least 65 13F filings, 2 13D filings, 52 13G filings, and 1 Form 4 filings

2023-12-31

Top Buys (13F)

2023-12-31

Top Sells (13F)

2023-12-31

13F Holdings Summary

Name $ Change
BHVN Biohaven Pharmaceuti 17.38%
ALDX Aldeyra Therapeutics 15.92%
APLT Applied Therapeutics 15.19%
AVDL Avadel Pharmaceutica 7.02%
SIL Global X Silver Mine 4.13%

2023-12-31

13F Activity

Market Value $121m, Prior: $96.3m
New Purchases 4 stocks
Added To 9 stocks
Sold out of 9 stocks
Reduced holdings in 1 stocks
Top 10 Holdings % 74.18%
Turnover %[1] 40.63%
Turnover Alt %[2] 6.83%
Time Held Top 20 5.95 quarters
Time Held Top 10 5.8 quarters
Time Held All 7.44 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2023-12-31

13F Sector Allocation Over Time

2023-12-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31

Portfolio Performance